期刊文献+

健脾补肾方联合二甲双胍对多囊卵巢综合征患者内分泌及糖脂代谢的影响 被引量:15

Efficacy of Jianpibushen Recipe joint Metformin in endocrine and biochemical features of obese PCOS patients
原文传递
导出
摘要 目的:观察健脾清补肾方联合二甲双胍对肥胖型多囊卵巢综合征(PCOS)患者内分泌及糖脂代谢的影响。方法:中西医结合治疗组:34例肥胖PCOS患者应用二甲双胍500mg/次,3次/d,同时口服健脾补肾方每日1剂,早晚分服,共3个月;西药组:34例肥胖PCOS患者单用二甲双胍500mg/次,3次/d,连续3个月。比较治疗前后临床症状、内分泌及糖脂代谢指标的改变。结果:治疗后中西医结合组中20例患者恢复了月经,西药组中16例患者恢复了月经。两组患者治疗前后腰臀比、促黄体生成素、雄激素、空腹胰岛素、胰岛素曲线下面积明显降低,胰岛素敏感指数明显提高,有显著性差异(P<0.05)。在血脂改善方面,中西医结合组患者治疗后,总胆固醇、甘油三酯、低密度脂蛋白、载脂蛋白B均明显下降(P<0.05,P<0.01);西药组患者治疗后,只有总胆固醇、载脂蛋白B下降,余指标无明显改变。结论:健脾补肾方联合二甲双胍可明显降低肥胖型多囊卵巢综合征患者促卵泡素、雄激素水平,提高胰岛素的敏感性,降低血脂水平,减少二甲双胍的副作用,提高患者依从性,尤其是对血脂的改善明显优于西药组。 Objective: The aim of our study is to assess the effects of Jianpibushen Recipe joint Metformin in endocrine and biochemical features of obese PCOS patients.Methods: thirty-four obsess PCOS patients were administrated metfomin 500mg three times daily joint Jianpibushen Recipe one dose of medicine every day,morning and evening hours service for three months.Thirty-four obsess PCOS patients were administrated metfomin 500mg three times for three months only.Baseline characteristics were assessed initially and 3 months after treatment in two groups.Results: twenty patients achieved regular menstrual periods in integrative medicine group and sixteen patients in Metformin group,A significant reduction occurred in WHR,LH,T,FINS,IAUC and a significant increasing occurred in ISI in integrative medicine Group(P0.05).In Metformin group,A significant reduction occurred in TCH,TG,LDL-c,ApoB(P0.05,P0.01) and ISI increased significantly.Conclusion: Three months of Jianpibushen Recipe joint Metformin can reduce LH and T levels,increase insulin sensitivity and reduce the side effects of Metformin,especially in improving lipid metabolism;it was superior than Metformin therapy.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2011年第11期2682-2684,共3页 China Journal of Traditional Chinese Medicine and Pharmacy
关键词 多囊卵巢综合征 二甲双胍 健脾补肾方 肥胖 Polycystic ovary syndrome Metformin Jianpibushen Recipe Obese
  • 相关文献

参考文献7

  • 1Evanthia Diamanti-Kandarakis E,Christakou C D,Kandaraki E.Metformin:an old medication of new fashion:evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome.Ettr J Endocrinol,2010,162(2):193-212.
  • 2The Rotterdam ESHRE//ASRM-Sponsored PCOS Workshop Group.Revised 2003 consensus on diagnostic criteria and long- term health risks related to Polycystic ovary syndrome.Fertil Steril,2004,81 (1): 19-25.
  • 3国家中医药管理局.中华人民共和国医药行业标准.中医病症诊断疗效标准[M].南京:南京中医药大学出版社,1994.201-203.
  • 4郑建淮,曹缵孙,陈晓燕,扬卉,毛文军.胰岛素增敏剂治疗多囊卵巢综合征伴胰岛素抵抗临床疗效观察[J].生殖医学杂志,2003,12(1):3-8. 被引量:9
  • 5Cheang K I,Huszar J M,Best A M,et al.Long-term effect of metformin on metabolic parameters in the polycystic ovary syndrome.Diab Vasc Dis Res,2009,6(2): 110-119.
  • 6Vicenzo D L,Ant oniola M,Raoul O,et al.Effect of metformin on Instdin2 Like growth factor (IGF) I and IGF2 Binding protein I in polycystic ovary syndrome.The Journal Clinical Endocrinology & Metabolism,2000,85(4):1598-1600.
  • 7Palomba S,Falbo A,Russo T.et al.Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS):relationship to the ovulatory response.Hum Reprod,2010,25(4): 1005-1013.

二级参考文献3

共引文献473

同被引文献185

  • 1佀雪平,丛惠芳,王晓滨.针药并用治疗多囊卵巢综合征排卵障碍的疗效观察[J].针灸临床杂志,2007,23(8):35-36. 被引量:23
  • 2叶海涌,刘健,楼宜嘉.淫羊藿苷衍生物的制备及其雌激素样作用研究[J].浙江大学学报(医学版),2005,34(2):131-136. 被引量:42
  • 3陈子江.高度重视多囊卵巢综合征的规范化诊断与治疗[J].中华妇产科杂志,2007,42(5):289-290. 被引量:69
  • 4吴建辉,俞超芹,周巧玲,韩洁,王针织,沈慰.补肾化瘀祛痰方治疗多囊卵巢综合征的临床研究[J].中国中西医结合杂志,2007,27(10):883-886. 被引量:34
  • 5zziz R, Wood KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. The Journal of Clinical Endocrinology and Metabolism , 2004 ; 89 ; 2745- 2749.
  • 6Legro RS, The genetics of obesity. Lessons for polyeystie ovary syndrome. Annals of the New York Academy of Sciences ,2000; 900 : 193-202.
  • 7Zawadzki JK & Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Dunaif A, Givens JR, Hasehine FP& Merriam GR (eds.) Polycystic Ovary Syndrome. Boston : Blackwell Scientific Publications, 1992:377-384.
  • 8Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome ( PCOS). The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group [ J ]. Hum Reprod ,2004 ; 19 ( 1 ) : 41-47.
  • 9Tanaka T, Fujimoto S. Endocrinological environment of polycystic ovarian disease [ J ]. Horm Res, 1990,33 ( Suppl 2 ) :5 - 9.
  • 10Tehrani FR, Simbar M, Tohidi M, et al. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study[J].Reprod Biol Endocrinol,2011,9:39.

引证文献15

二级引证文献122

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部